Ftse Mib
34.500,59
-0,69%
DAX
20.353,22
0,19%
S&P 500
6.074,08
0,38%
NASDAQ
20.173,89
1,24%
Bitcoin
107.031,41
0,89%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Reviva Pharmaceuticals Holdings Inc (RVPH) Reviva Pharmaceuticals Holdings Inc (RVPH) Notizie

RVPH

Reviva Pharmaceuticals (RVPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RVPH
DataOraFonteTitoloSimboloCompagnia
23/08/202422:06Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202423:04Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
22/08/202415:28Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
21/08/202423:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/08/202414:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/02/202422:32Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
13/02/202423:00Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
02/02/202422:38Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323:19Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
04/10/202323:03Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/06/202312:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
15/05/202322:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
05/05/202322:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
27/04/202322:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314:12Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202314:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
30/03/202313:52Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
14/02/202322:03Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
16/11/202220:35TipRanksReviva Pharmaceuticals Holdings (RVPH) Receives a Buy from Maxim GroupNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
17/08/202217:25TipRanksMaxim Group Keeps Their Buy Rating on Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/06/202214:35GlobeNewswire Inc.Life Sciences Investor Forum Presentations Now Available for On-Demand ViewingNASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/03/202212:30GlobeNewswire Inc.Reviva Pharmaceuticals Holdings, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202221:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
23/03/202211:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/01/202222:15Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
24/01/202212:15TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Alnylam Pharma (ALNY), Reviva Pharmaceuticals Holdings (RVPH)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
26/10/202113:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
03/06/202123:31Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
28/05/202122:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:RVPHReviva Pharmaceuticals Holdings Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RVPH

La tua Cronologia

BIT
TIT
Telecom Italia
BIT
ENI
Eni
BIT
TITR
Telecom Italia
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
STLAM
Stellantis NV
BIT
BPE
Bper Banca
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
RACE
Ferrari NV
BIT
STMMI
ST Microelectronics
BIT
SPM
Saipem
BIT
BAMI
Banco BPM
BIT
MONC
Moncler
BIT
CPR
Davide Campari
BIT
LDO
Leonardo
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network